123 related articles for article (PubMed ID: 8950476)
1. The role of Fas/FasL interactions in the regulation of B cell function.
Jacobson BA; Rothstein TL; Marshak-Rothstein A
Behring Inst Mitt; 1996 Oct; (97):185-99. PubMed ID: 8950476
[TBL] [Abstract][Full Text] [Related]
2. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
Siegel RM; Chan FK; Chun HJ; Lenardo MJ
Nat Immunol; 2000 Dec; 1(6):469-74. PubMed ID: 11101867
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
[TBL] [Abstract][Full Text] [Related]
4. Fas receptor signaling is requisite for B cell differentiation.
Pasqualetto V; Vasseur F; Zavala F; Schneider E; Ezine S
J Leukoc Biol; 2005 Nov; 78(5):1106-17. PubMed ID: 16266974
[TBL] [Abstract][Full Text] [Related]
5. Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.
Mabrouk I; Buart S; Hasmim M; Michiels C; Connault E; Opolon P; Chiocchia G; Lévi-Strauss M; Chouaib S; Karray S
Immunity; 2008 Dec; 29(6):922-33. PubMed ID: 19013083
[TBL] [Abstract][Full Text] [Related]
6. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
Nagata S
J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
[TBL] [Abstract][Full Text] [Related]
7. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
[TBL] [Abstract][Full Text] [Related]
8. T cells commit suicide, but B cells are murdered!
Scott DW; Grdina T; Shi Y
J Immunol; 1996 Apr; 156(7):2352-6. PubMed ID: 8786289
[TBL] [Abstract][Full Text] [Related]
9. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
Weintraub JP; Eisenberg RA; Cohen PL
J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
[TBL] [Abstract][Full Text] [Related]
11. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
Hirohata S
Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
15. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
Cheng J; Liu C; Yang P; Zhou T; Mountz JD
J Immunol; 1997 Jul; 159(2):674-84. PubMed ID: 9218582
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune disease results from multiple interactive defects in apoptosis induction molecules and signaling pathways.
Mountz JD; Zhou T; Su X; Cheng J; Pierson M; Bluethmann H; Edwards CK
Behring Inst Mitt; 1996 Oct; (97):200-19. PubMed ID: 8950477
[TBL] [Abstract][Full Text] [Related]
17. In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice.
Mahiou J; Walter U; Lepault F; Godeau F; Bach JF; Chatenoud L
J Autoimmun; 2001 Jun; 16(4):431-40. PubMed ID: 11437491
[TBL] [Abstract][Full Text] [Related]
18. Activation-induced cell death in T cells and autoimmunity.
Zhang J; Xu X; Liu Y
Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
20. B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo.
Kosiewicz MM; Krishnan A; Worthington MT; Matriano JA; Ross WG
Eur J Immunol; 2002 Jun; 32(6):1679-87. PubMed ID: 12115651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
